SpliSense anticipates top-line results in the second half of 2027.

The biotech company is downsizing to fund another trial after a drug showed no meaningful benefit. The move comes just a year ...

People with cystic fibrosis do not usually have a higher risk of COVID-19 when compared to people without this condition. They also typically have an infection course similar to people without cystic ...

To keep the resources flowing to this new strategy, Sionna is reducing its headcount by around 46%, including the departure ...

Supportive therapy, like medications to help open the airways and heal infections, can help you live a healthier life and meet many of the challenges of this inherited respiratory condition. Share on ...

Claire Wineland used honesty and humor to share life with cystic fibrosis ...

For decades, lung disease has been the most visible and life-threatening part of cystic fibrosis. People might picture chronic (long-term) cough, breathlessness, recurrent chest infections and oxygen ...

A documentary offers a history of cystic fibrosis and the medical advancements in combatting it.

Cystic fibrosis, one of the most common genetic diseases in Switzerland, promotes chronic bacterial infections by impairing ...

A new study from Epic Research, a health analytics firm based in Verona, Wisconsin, detected some encouraging news for those who suffer from cystic fibrosis (CF). In 2008, the average life expectancy ...

Sionna Therapeutics will cut around 46% of its workforce to focus its resources on developing a cystic fibrosis treatment.

Breathing disorders are common in the U.S. with conditions like COPD affecting some 7% of the population and asthma affecting another 10%. Digestive conditions like GERD, acid reflux, Celiac disease ...